HEADER MENU Health professionals Media Contact Advice and prevention sites Medications Search SEARCH NEWS THERAPEUTIC AREAS R&D COMMITMENTS KNOW US Advances that change patients' lives CONTACTS CONTACT US Find here the various numbers, addresses and useful links to contact us according to your needs: medical information, pharmacovigilance, orders, Health Authority ... LEARN MORE NEWS IT'S TIME TO ACT! COVID-19 has changed our daily lives, our habits and our lifestyles. But one thing COVID-19 must not impact is access to cancer care. LEARN MORE PRESS RELEASES 21 October 2021 Acromegaly: a rare disease unknown to 82% of French people surveyed. October 14, 2021 Rare diseases: only 2% of French people surveyed know that they affect more than 3 million of their fellow citizens. FIND OUT MORE TWEETS BY PFIZER_FRANCE R&D OUR R&D IN FRANCE In France, our R&D model is open to partnerships, whether academic or forged with biotechnology companies. LEARN MORE NEWS 6 WOMEN TESTIFY TO INFORM AND RAISE AWARENESS ABOUT METASTATIC BREAST CANCER Since 2015, Pfizer has been developing its SeinChrone initiative. LEARN MORE NEWS LESSONS FROM THE COVID-19 PANDEMIC Our President looks back on the race against time which resulted in the development of the 1st vaccine against SARS-Cov2. LEARN MORE MAIN NAVIGATION NEWS Your health Our R&D Our engagements Our enterprise THERAPEUTIC AREAS Cancers Rare diseases Vaccine prevention Cardiovascular illnesses Infectious diseases Inflammation & immunology Smoking cessation R&D Our R&D in France Our R&D in the world Patient information Pfizer Innovation France COMMITMENTS Patient commitments Responsible Company Ethics and transparency KNOW US Pfizer in France The Pfizer Group Our advances for health Working at Pfizer MISCELLANEOUS TERMS OF SERVICE WHO ARE WE ? INFORMATION ABOUT COOKIES PERSONAL DATA INFORMATION NOTICE PP-GIP-FRA-1849 SOCIAL LINKS Copyright © 2020-2021 Pfizer Inc. All rights reserved. The content of this site is intended for people residing in France.